Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clas Malmeström

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Antimicrobial Agents and Chemotherapy|July 25, 2003
Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovirJan Lycke, Clas Malmeström, Lars Ståhle
Acta Neurologica Scandinavica|June 14, 2020
Cerebrospinal fluid CD4<sup>+</sup> /CD8<sup>+</sup> ratio in diagnosing neurosarcoidosisSara Nordström, Bengt Andersson, Clas Malmeström
Brain and Behavior|October 8, 2019
Neuronal antibodies in adult patients with new-onset seizures: A prospective studyJohan Zelano, Markus Axelsson, Radu Constantinescu, et al.
Journal of Neuroimmunology|October 16, 2013
The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosisMarkus Axelsson, Niklas Mattsson, Clas Malmeström, et al.
Neuroscience Letters|August 17, 2010
Processing in prefrontal cortex underlies tactile direction discrimination: An fMRI study of a patient with a traumatic spinal cord lesionLinda C Lundblad, Håkan W Olausson, Clas Malmeström, et al.
Journal of Neuroimmunology|March 4, 2014
CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatmentClas Malmeström, Markus Axelsson, Jan Lycke, et al.
Journal of Neuroimmunology|March 6, 2016
YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosisJoachim Burman, Raili Raininko, Kaj Blennow, et al.
BMC Immunology|July 31, 2013
MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS)Margareta Jernås, Clas Malmeström, Markus Axelsson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 25, 2013
Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosisMarkus Axelsson, Clas Malmeström, Martin Gunnarsson, et al.
Multiple Sclerosis and Related Disorders|April 2, 2026
Calprotectin reveals distinct innate immune signatures in NMOSD, MOGAD, and multiple sclerosisMagnus Johnsson, Jan Lycke, Lenka Novakova, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|July 25, 2003
Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovirJan Lycke, Clas Malmeström, Lars Ståhle
Acta Neurologica Scandinavica|June 14, 2020
Cerebrospinal fluid CD4<sup>+</sup> /CD8<sup>+</sup> ratio in diagnosing neurosarcoidosisSara Nordström, Bengt Andersson, Clas Malmeström
Brain and Behavior|October 8, 2019
Neuronal antibodies in adult patients with new-onset seizures: A prospective studyJohan Zelano, Markus Axelsson, Radu Constantinescu, et al.
Journal of Neuroimmunology|October 16, 2013
The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosisMarkus Axelsson, Niklas Mattsson, Clas Malmeström, et al.
Neuroscience Letters|August 17, 2010
Processing in prefrontal cortex underlies tactile direction discrimination: An fMRI study of a patient with a traumatic spinal cord lesionLinda C Lundblad, Håkan W Olausson, Clas Malmeström, et al.
Journal of Neuroimmunology|March 4, 2014
CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatmentClas Malmeström, Markus Axelsson, Jan Lycke, et al.
Journal of Neuroimmunology|March 6, 2016
YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosisJoachim Burman, Raili Raininko, Kaj Blennow, et al.
BMC Immunology|July 31, 2013
MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS)Margareta Jernås, Clas Malmeström, Markus Axelsson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 25, 2013
Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosisMarkus Axelsson, Clas Malmeström, Martin Gunnarsson, et al.
Multiple Sclerosis and Related Disorders|April 2, 2026
Calprotectin reveals distinct innate immune signatures in NMOSD, MOGAD, and multiple sclerosisMagnus Johnsson, Jan Lycke, Lenka Novakova, et al.
Pageof 6